Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.

MLA

Longenecker, Chris T., et al. “Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.” JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 69, no. 2, June 2015, pp. 168–77. EBSCOhost, https://doi.org/10.1097/QAI.0000000000000557.

APA

Longenecker, C. T., Kitch, D., Sax, P. E., Daar, E. S., Tierney, C., Gupta, S. K., & McComsey, G. A. (2015). Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 69(2), 168–177. https://doi.org/10.1097/QAI.0000000000000557

Chicago

Longenecker, Chris T., Douglas Kitch, Paul E. Sax, Eric S. Daar, Camlin Tierney, Samir K. Gupta, and Grace A. McComsey. 2015. “Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.” JAIDS: Journal of Acquired Immune Deficiency Syndromes 69 (2): 168–77. doi:10.1097/QAI.0000000000000557.